Standard InChI: InChI=1S/C39H73NO13/c1-15-27-39(12,47)32(43)22(6)29(41)20(4)17-37(10,46)34(53-36-30(42)26(16-21(5)49-36)40(13)19(2)3)23(7)31(24(8)35(45)51-27)52-28-18-38(11,48-14)33(44)25(9)50-28/h19-34,36,41-44,46-47H,15-18H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1
Standard InChI Key: RXJCJWPPKSQMAS-IRNFSOKPSA-N
Associated Targets(Human)
HERG 29587 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Motilin receptor 232 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Streptococcus pneumoniae 31063 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 764.01
Molecular Weight (Monoisotopic): 763.5082
AlogP: 2.36
#Rotatable Bonds: 8
Polar Surface Area: 197.07
Molecular Species: BASE
HBA: 14
HBD: 6
#RO5 Violations: 3
HBA (Lipinski): 14
HBD (Lipinski): 6
#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.46
CX Basic pKa: 9.63
CX LogP: 2.69
CX LogD: 0.48
Aromatic Rings: 0
Heavy Atoms: 53
QED Weighted: 0.20
Np Likeness Score: 1.62
References
1.Shaw SJ, Chen Y, Zheng H, Fu H, Burlingame MA, Marquez S, Li Y, Claypool M, Carreras CW, Crumb W, Hardy DJ, Myles DC, Liu Y.. (2009) Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety., 52 (21):[PMID:19821563][10.1021/jm901107f]
2.Liu Y, Li Y, Myles DC, Claypool M, Carreras CW, Shaw SJ.. (2010) 9-Dihydroerythromycin ethers as motilin agonists--developing structure-activity relationships for potency and safety., 18 (21):[PMID:20869254][10.1016/j.bmc.2010.08.035]
3.Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ.. (2011) The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series., 21 (12):[PMID:21570844][10.1016/j.bmcl.2011.04.078]